← Open Payments lookup

DIANA O'NEIL: Open Payments

NPI 1982861720 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,481 in 135 payments from 10 companies in 2025. Trend: 2023 $182 · 2024 $580 · 2025 $1,481

Food & beverage: $1,481
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.95$639
ABBVIE INC.11$196
E.R. Squibb & Sons, L.L.C.6$186
Janssen Pharmaceuticals, Inc4$103
Alkermes, Inc.4$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$76
Otsuka America Pharmaceutical, Inc.3$69
Takeda Pharmaceuticals U.S.A., Inc.4$67
Teva Pharmaceuticals USA, Inc.2$34
Vanda Pharmaceuticals Inc.1$17

Products named: INGREZZA, VRAYLAR, COBENFY, INVEGA, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII, TRINTELLIX.

Industry payments across FL — which companies pay providers there.